the cerebellum is a prominent part of the vertebrate hindbrain that is critically involved in the regulation of important body functions such as movement coordination, maintenance of balance and posture, and motor control. Here, we describe a cerebellar window that provides access to the mouse cerebellum for intravital imaging, thereby allowing for a detailed characterization of the dynamic processes in this region of the brain. First, the skull overlying the cerebellum is removed, and then the window is applied to the region of interest. Windows may be exchanged depending on the desired imaging modality. this technique has a variety of applications. In the setting of medulloblastoma, spontaneous or orthotopically implanted lesions can be imaged, and tumor morphology and size can be monitored using ultrasonography. Multiphoton laser-scanning microscopy (MplsM) or opticalfrequency-domain imaging (oFDI) can be applied for in vivo visualization and analysis of cellular and vascular structures in a variety of disease states, including malignancies and ataxia telangiectasia. this protocol describes a novel and rapid method for cerebellar window construction that can be set up in under an hour.
IntroDuctIon
The cerebellum is a critical region of the vertebrate hindbrain that is responsible for integrating sensory-input signals into coordinated muscular movement. It may be adversely affected in a number of pathological conditions, including genetic neurodegenerative disease, such as ataxia telangiectasia; inflammatory states, such as cerebellitis; and neoplasias, including medulloblastoma. Intravital imaging is critical to gaining a better understanding of these conditions. Pediatric medulloblastoma, of particular interest to our group, is the most common malignant brain tumor in children and represents a complex clinical problem. Standard-of-care treatments, including radiation, surgical resection, and chemotherapy, vary greatly in efficacy, but cause substantial morbidity and quality-oflife reduction in patients. Preclinical models are key to developing and testing novel, more efficacious, and safer therapies. In vivo imaging is necessary, in order to study tumor initiation, growth, morphology, and response to therapy.
The intact mouse skull is sufficiently thick to prevent direct imaging of the brain with high resolution. One technique used to circumvent this obstacle is to thin the cranial bone to a thickness (~20 µm) that allows optical imaging [1] [2] [3] , albeit with a slight loss of resolution. To optimize imaging fidelity, we and others developed chronic cranial windows, a technique in which a circular area of the cranial bone is replaced with a glass coverslip through which the cortex can be imaged in live [4] [5] [6] , and even awake 7 , mice. In this protocol, we describe how to insert a cerebellar window into mice. We developed this method to facilitate our study of preclinical models of medulloblastoma 8 , although the window has potential applications beyond the study of brain tumors, as discussed below. This window was used for the preclinical investigation of critical tumor-stroma interactions across medulloblastoma subtypes 8 , and use of the cerebellar window greatly aided in studies that identified the role of the PlGF/Nrp1 pathway in pediatric medulloblastoma 8 .
Applications of the protocol
In the context of cancer, cranial-window techniques may be used to longitudinally study brain tumors in the cortical area, including glioblastoma and breast cancer brain metastases [9] [10] [11] [12] [13] [14] . In particular, cranial windows enable intravital MPLSM, which is useful for observing the dynamic growth and migration of fluorescently labeled tumor cells. When used in the setting of stromal architecture also tagged with a fluorochrome, or when imaging stromal components that exhibit second-harmonic generation, it is possible to study the interaction of the tumor and its stromal milieu at subcellular resolution. Imaging of drug delivery by MPLSM can also be facilitated by studying compounds that are inherently fluorescent or by using antibody conjugates that bear fluorescent tags 15 . To complement MPLSM, OFDI 11, 16 can provide a highresolution map of the vasculature in normal, premalignant, or tumorous tissue. In addition, high-frequency ultrasonography may be used in order to accurately measure the tumor volume, especially at depths at which the other imaging modalities are unable to function. Importantly, this technique can be coupled to the measurement of Gaussia luciferase (Gluc) levels in the blood of mice bearing stably transduced tumors 17, 18 , thereby allowing for the noninvasive measurement of tumor volume in situations in which direct imaging is impractical or unavailable.
Although tumors in the murine cortical region have been extensively imaged via intravital methodologies, tumors arising in the cerebellum, such as medulloblastoma, have received comparatively less attention. Previous studies used approaches such as MRI to measure medulloblastoma volume 19, 20 , but this technique is costly and time-consuming, making arbitrary or serial A cerebellar window for intravital imaging of normal and disease states in mice measurements infeasible. To study these tumors, it is imperative to adapt and suit the imaging modalities to the unique topology of the cerebellum. Here, we present an optimized version of the cranial window, which we term a 'cerebellar window', and which can be used for optical access to the mouse cerebellum. In this technique, we confine the region of skull replacement to the area overlaying the cerebellum. Furthermore, the choice of the imaging modality can be optimized through the use of a glass (for MPLSM or OFDI) or polyethylene (for ultrasonography) coverslip. Importantly, we demonstrate that constitutively expressed, tumor-cell-specific Gluc can be measured in the blood and used as a surrogate measure of tumor volume, once ultrasonography has been used to standardize the tumor volume as a function of blood Gluc levels. Moreover, the cerebellar window allows for the rapid detection and monitoring of spontaneous medulloblastoma in genetically engineered mouse models (GEMMs). In addition, we show that salient features of the tumor pathophysiology, including tumor vessel morphology and drug delivery, can be accurately described during a clinically relevant medulloblastoma treatment protocol.
Alternative methods
Studying the onset and progression of pediatric medulloblastoma in mouse models, especially GEMMs, is very challenging, mostly owing to the heterogeneity in latency, location, and growth pattern, as well as the lack of clinical symptoms at early stages of the disease. Owing to excellent tissue contrast, MRI represents the state-of-the-art clinical-imaging modality for medulloblastoma, other brain tumors, and indeed for most cerebellar disease states. However, the use of conventional MRI, which does not require the establishment of a window, in preclinical models is very challenging, and, in most cases, it is limited to determining tumor progression at later, advanced stages of the disease 21, 22 . Recently, more advanced MRI protocols for high-resolution imaging of medulloblastoma tumors at early stages in mice have been developed and optimized 20 . However, these approaches have some limitations. High-resolution imaging is very time-consuming, whereas rapid, high-throughput imaging can be performed at the expense of resolution 20 . Despite recent advances, the resolution limit of MRI-based approaches is ~50 µm.
Advantages and limitations
Performing qualitative and quantitative analysis of dynamic biological events requires high-resolution imaging technologies. The development of such technologies, including MPLSM and OFDI 11 , has facilitated the mechanistic exploration of pathophysiological processes in tumors. However, these technologies require, in most cases, direct optical access to the tumor through a window 23, 24 . The cerebellar window presented here provides optical access to the mouse cerebellum, allowing the intravital imaging of medulloblastomas.
Experimental design
Here, we describe a protocol for implementing a window-based approach for imaging the murine cerebellum (Fig. 1) . The cerebellar window provides optical access to the mouse cerebellum and can be used for multimodal visualization of structural, morphological, and functional characteristics of both normal tissue and malignancies in this environment. Moreover, the development and growth of both implanted and spontaneous cerebellar tumors can be effectively monitored, vessel features can be measured, and drug delivery can be determined. In addition, there are a number of critical steps as noted in the detailed protocol that require preparation before beginning this study. For instance, it is useful-at the study's inception-to map the imaging that is necessary throughout, as this will inform the choice, timing, and placement of the respective coverslips that are specific to each imaging modality. In addition, it is important that all surgical tools be sterilized (we autoclave all surgical tools routinely) before beginning the procedure.
Below we present some technical considerations.
Surgery and follow-up care. The surgical procedure used to implant the window, the follow-up care, and the subsequent imaging each present a number of technical considerations that are important determinants of successful long-term intravital imaging. The portion of the skull overlying the cerebellum can be removed and the coverslip can be placed in a single surgical event. However, it is recommended to wait for at least 1 week for potential inflammation to subside before imaging. After this period, tumor cells can be implanted (when desired) during a second surgery (Supplementary Fig. 1 ). This second surgery is not required in imaging GEMMs. Although a second surgery under anesthesia presents a health risk to the mouse, it is important that implantation does not occur in the setting of local inflammation, as the tumor kinetics becomes more variable and the model less faithfully represents the clinical reality. Despite previous reports of reactive gliosis in the cortex after implantation of a cranial window 6 , analysis of the cerebellum 2 d and 10 d after cerebellar window implantation did not reveal clear glial activation as compared with the control tissue (Supplementary Fig. 2 ).
The quality of each surgery and the health of the mouse are also key determinants of imaging quality, as hemorrhage or tissue damage can obscure key features of the brain and tumor architecture. The dura mater, if left intact during the initial surgical procedure, can thicken over time, leading to loss of optical quality 6 . Once the cerebellar window is established, the coverslip can be changed to accommodate multiple imaging modalities. However, each change requires surgical intervention and carries the risks associated with any invasive procedure that involves anesthesia. Therefore, although the coverslip can be changed, we do so sparingly. Once a coverslip is affixed to the cranium, it is possible to image longitudinally for a period of up to about five months, after which time, bone regrowth can limit the resolution and imaging quality.
Imaging method selection. Immunohistochemical (IHC) analysis is the most widely used method to investigate tumor biology by imaging. However, these static images do not permit the examination of dynamic changes occurring during the natural history of the disease. Intravital microscopy allows longitudinal and quantifiable imaging of the orthotopic environment. The use of transparent windows, as described in our protocol, has substantially transformed our view of tumors. However, the selection of the most appropriate imaging method is essential.
The quantification of microvascular perfusion is a prime example of the measurement of the same biological feature using different methods of imaging. Microbubble injection combined with ultrasonography allows the quantification of perfusion of the whole volume of the tumor, with low resolution but with a wide field of view 25 . OFDI permits fast and accurate imaging, and quantification of perfused vessels and their geometry within the 1-mm most superficial layer of tissue of the whole transparent window area with no need for tracers, but it is unable to visualize nonperfused vessels. MPLSM may be more versatile, but is timeconsuming and limited in imaging depth; it can be combined with injection of labeled red blood cells to quantify blood-flow velocity 26 with endothelial cell reporter mice and injection of blood-flow tracers to visualize perfused and nonperfused vessels, or can be combined with other fluorescently tagged cells of the tumor microenvironment to visualize how these cells modify vascular perfusion locally 27, 28 . IHC of lectin-perfused tissues can be used to confirm the results from intravital microcopy (IVM) in terms of the percentage of perfused vessels 29 . Methods that do not require a window model, such as MRI or micro-CT, can also provide a measurement of blood flow and/or perfusion 30 ; however, they are limited in spatial resolution, and thus cannot resolve the tumor microvasculature. The use of ex vivo micro-CT imaging of vascular casts can provide a 3D high-resolution image of the microvasculature 31 , but, similar to IHC, it represents a single, static time point. Imaging and tumor-volume assessment were performed through a cerebellar window using a polyethylene coverslip and a Vevo 2100 high-frequency ultrasonography device (FujiFilm VisualSonics). All animal procedures were performed according to the guidelines of the Public Health Service Policy on Human Care of Laboratory Animals and in accordance with a protocol approved by the Institutional Animal Care and Use Committee of Massachusetts General Hospital. All cell lines used in the experiments depicted were tested both for authenticity (by short tandem-repeat typing) and for mycoplasma contamination, and certified to be both authentic medulloblastoma cell lines and mycoplasma free. All cell lines used in the experiments depicted were tested both for authenticity (by short tandem-repeat typing) and for mycoplasma contamination and were certified to be both authentic medulloblastoma cell lines and mycoplasma free. RT, radiation therapy.
Sample size calculation.
To obtain a sufficient number of mice with cerebellar windows, the survival rate post surgery should be considered. Even when considering the need for multiple surgeries in order to introduce tumor cells into the cerebellum, the overall survival rate after multiple surgical interventions for most mouse strains lies between 70 and 90%. This number varies with the experience and skill level of the scientist performing the surgeries.
Cost and time. The cerebellar window approach described in this protocol costs relatively little in terms of reagents. We have noted that, on occasion, mice mechanically interfere with or attempt to displace their cage mates' cerebellar windows. For this reason, we customarily house them individually after implantation of a cerebellar window. In the case of xenograft tumors, the mice must be housed for at least 10 d before implantation of tumors. This is of particular importance if any immunological studies are planned, as recovery from inflammation, as described above, is necessary before tumor-cell implantation or imaging of processes at single-cell resolution. After tumor-cell implantation, the mice should be housed for a healing period of at least 3-7 d. The time line for an experimental study routinely extends up to several weeks or months; in the setting of tumors, this number depends on many variables, including tumor latency, rate of growth, and efficacy of treatments administered, among other factors. Cost calculations for studies of mice with cerebellar windows must therefore also consider animal housing during this time period. In regard to the time and effort necessary to establish cerebellar windows, the implantation of a cerebellar window takes about 45-60 min. However, this minimal time requires high surgical expertise; absent this, implantation may take longer.
Applications of the cerebellar window
Small-animal ultrasonography. Ultrasonographic (US) imaging represents an attractive imaging modality for the evaluation of therapeutic response in oncology. Major advantages of US imaging include an excellent temporal resolution without exposure to irradiation. The development of 3D dynamic-contrast-enhanced (3D-DCE) US imaging allows not only the accurate volumetric measurement of tumor size but also the monitoring of functional parameters, such as tumor perfusion. In this way, US imaging enables not only the noninvasive longitudinal evaluation and quantification of morphologic and anatomic changes in tumors but also the quantification of treatment effects before the morphological changes become visible 32 . US imaging is widely used for tumor imaging in preclinical models. Small-animal ultrasound imaging includes the detection of tumors and their metastases 33, 34 , the monitoring of tumor growth and response to therapies 13, 35 , as well as the characterization of the tumor vascularity 36, 37 . High-resolution US imaging of the brain or the cerebellum is limited because of the high acoustic impedance of the bones of the skull. A cranial window with a polyethylene coverslip allows sound waves to pass through the brain tissue and therefore permits the high-resolution imaging of primary and secondary brain tumors. This procedure has been extensively utilized by our group for the evaluation of therapeutic drugs in preclinical models of glioblastoma and brain metastases 13, 29 .
The cerebellar window described in this protocol allows the high-resolution ultrasound imaging of stereotactically implanted (Fig. 2a) or spontaneous medulloblastoma tumors (Fig. 2b) in mouse models. For our studies, we use the VisualSonics Vevo2100 High-Resolution Ultrasound System. With respect to spontaneous medulloblastoma in GEMMs, ultrasound imaging is a very efficient and advantageous alternative to MRI-based imaging, primarily because of the necessity for serial imaging, as (i) the tumor onset and development of these tumors cannot be predicted, and (ii) repeated imaging and quantification of the tumor volume is necessary to obtain essential information on tumor growth kinetics. Serial ultrasound-based imaging is both time-and cost-effective: Ultrasonography through the cerebellar window, including data analysis, can be performed within 15-30 min. Moreover, using a 3D motor frame and a stereotactic system, ultrasound imaging allows the rapid 3D reconstruction of tumor volume for medulloblastoma tumors (Fig. 2c) .
In addition, rapid ultrasonography-based imaging of implanted medulloblastoma models can be applied for the evaluation of indirect surrogates of tumor growth. Specifically, we have previously developed orthotopic models of medulloblastoma using human tumor cells that were engineered to express secretable Gluc in the blood 8 . Gluc expression in the tumor can be used for local detection and visualization of cerebellar tumors with bioluminescence imaging (Fig. 3a) . Gluc activity in serum can additionally be used as a precise surrogate measure to monitor tumor growth, provided that there is a strong correlation between Gluc activity and real tumor volume. Concomitant measurement of the 3D tumor volume using ultrasound and Gluc activity in the serum provides important information on the correlation between the two parameters (Fig. 3b) . Furthermore, longitudinal imaging studies to test therapeutic response can be based on the fast and simple measurement of serum Gluc activity, rather than on the direct imaging of tumor burden (Fig. 3c,d) .
Ultrasound-based imaging of medulloblastoma tumors through a cerebellar window is a multistep approach that includes (i) preparation of the mice for imaging, (ii) 2D and/or 3D image acquisition, and (iii) postimaging analysis of the data; each of these steps can be performed within a time frame of 5-10 min.
Multiphoton microscopy. IVM allows the achievement of two key tasks in tumor biology: the behavioral observation of cells, tissues, and/or organs within the real environment (i.e., in vivo), and the quantification of biological and clinically relevant phenomena. Various parameters can be quantified by IVM. These can range from parameters disclosed by very high magnification-molecular and subcellular imaging (1-µm resolution), to those revealed by imaging at the cellular level-cell tracking (10-µm resolution), and finally to those displayed by functional-anatomical imaging-tumor size, vascular architecture, blood-flow rate, vascular permeability, drug distribution, and uptake (resolution from tens to hundreds of microns) 28, 38, 39 . To build an IVM model, four elements are needed: an appropriate animal model with a transparent window; a molecular fluorescent probe-injected fluorophoretagged tracers or reporter fluorescent proteins (produced by viral transduction or specific promoters in transgenic mice)-that can be imaged; a microscope with an appropriate imaging depth and equipped with an excitation source and a detection system; and image-analysis algorithms applied to extract quantitative data.
IVM has been a critical tool and has led to numerous discoveries in the field of tumor biology. Vascular functionality has been discovered to be strongly impaired in tumors 40 , so objective intravital visualizations and quantifications of perfusion 27 , pH, pO 2 and NO gradients [41] [42] [43] , red blood cell velocity 26 , permeability and pores 44 , diameter and architecture 11, 13, 45, 46 , and maturation 46, 47 of tumor vasculature are important tools to gain clinically relevant insights into tumor physiopathology.
IVM allows the quantification of rolling, extravasation, migration, and infiltration of macrophages, leukocytes and lymphocytes within the tumor mass, as well as the investigation of the involvement of fibroblasts during tumor progression [48] [49] [50] [51] [52] . Collagen fibers are important modulators of tumor stiffness and solid stress, and consequently of tumor progression and drug delivery 53, 54 . Impaired drug delivery within the tumor mass is an important and clinically relevant issue. IVM allows us to visualize the regions with low drug diffusion, delivery, and/or efficiency (e.g., small molecules, antibodies, liposomes, and nanoparticles) that occur in many tumors 40, 44, 55 . Finally, IVM has been essential in the description of the first steps of the process of formation of distant metastases 56 . IVM enabled the discovery and visualization of the involvement of cell-to-cell interactions of specific macrophages with metastatic tumor cells during the intravasation process 57, 58 .
Using the cerebellar window, multiphoton laser-scanning microscopy of cerebellar tumors is enabled (Fig. 4) . This allows the visualization of both tumor cells and the tumor vasculature in the microenvironment of the cerebellum, as well as (Fig. 4a-c ) the quantitative analysis of tumor characteristics (Fig. 4d,e) , which is necessary to better understand the pathophysiology of medulloblastoma.
Optical frequency-domain imaging. Optical coherence tomography (OCT), an imaging method that uses the light-scattering properties of soft tissue in order to generate high-resolution maps of anatomical structures, is extremely useful in preclinical imaging studies. Importantly, it is amenable to the study of the brain when used in tandem with a cranial window, and it has been shown to be extremely useful in delineating normal cerebellum from tumor tissue in genetically engineered mouse models of medulloblastoma 59 . In our laboratory, we use a second-generation form of OCT, known as optical frequency domain imaging (OFDI) 11 . Much like other in vivo imaging methods that capture high-resolution images, it is important that the mouse, or at least the anatomical location of the mouse that is to be studied, is immobilized during imaging sessions. It is only slightly inferior to MPSLM in terms of resolution, and is far superior to ultrasonography or MRI in this regard. OCT can be used to image tissue at depths of up to 2 mm, as it uses longer, near-infrared wavelengths of light. Its applications include cerebellar tumor volume measurements for smaller tumors, angiography, and assessment of tissue viability 24 . One advantage of this technology is that multiple biological parameters such as those described above can be assessed quickly in one scan. The entire brain/cerebellum can be imaged in 1-20 min; however, imaging time is inversely correlated to image contrast. Postprocessing analysis then yields a detailed picture of the parameter of interest (Fig. 5a,b) . It is also ideal for longitudinal studies and arbitrary repeated measurements, as OCT/OFDI does not require the addition of an exogenous label that may impair image quality over time (Fig. 5c) . In our laboratory, using the cerebellar window, it is possible to toggle between cerebellar ultrasonography and MPSLM/OFDI by simply applying a different coverslip to the cranium of the mouse; this allows us to capitalize on the relative strengths of multiple imaging modalities in a single study (for a comparison of these modalities, see ref. 44 ).
MaterIals

REAGENTS
Mice: Nude, SCID or nod-SCID mice are preferred for orthotopic implantation of human medulloblastoma cell lines. Nude, SCID and nod-SCID mice are bred and maintained at the Gnotobiotic Mouse Cox 7 Core at the Massachusetts General Hospital (https://researchcores.partners.org/cox/about). GEM medulloblastoma models (obtained from the Jackson Laboratory) are used for spontaneous medulloblastoma tumors ! cautIon All animal studies must be reviewed and approved by the relevant animal-care committees and must conform to all relevant institutional and national ethics regulations. All animal procedures were performed according to the guidelines of the Public Health Service Policy on Human Care of Laboratory Animals and were in accordance with a protocol approved by the Institutional Animal Care and Use Committee of Massachusetts General Hospital.  crItIcal For experiments on pediatric medulloblastoma, it is important to use young mice (4-6 weeks old).
Within one experiment, we recommend using only one gender of mice in order to minimize variability. Anesthesia: Ketamine (use at 90 mg/kg body weight) and xylazine (use at 9 mg/kg body weight). Both medications are added to sterile saline to obtain the described concentrations. Ketamine (Ketaset, 100 mg/ml; Patterson Veterinary, cat. no. 07-803-6637) and xylazine (AnaSed, 100 mg/ml, Patterson Veterinary, cat. no. 07-808-1939) Analgesia: Buprenorphine (Buprenex, 0.3 mg/ml; Patterson Veterinary, cat. no. 07-850-2280) is used at a concentration of 0.1 mg/kg  crItIcal Buprenorphine is to be injected s.c. Saline, sterile (to dilute ketamine and xylazine), sodium chloride, 0.9%, bacteriostatic, 30 ml (Hospira, cat. no. SKU ABB19660715Z) or similar Saline, 0.9%, for irrigation (Owens-Minor, cat. no. 0706-2F7123) Cell lines: the human pediatric medulloblastoma cell lines used in our studies are D283 and D341 (ATCC, cat. nos. HTB-185 and HTB-187) ! cautIon The authenticity of any cell line should be confirmed by short tandem-repeat allelotyping or another genetics-based confirmation method before use; the cell lines should also be confirmed to be mycoplasma-free. •
• proceDure surgery • tIMInG 45 min 1| Administer buprenorphine at 0.1 mg/kg body weight s.c. 15 min before surgery. Anesthetize the mouse with 90 mg/9 mg per kg body weight of a ketamine/xylazine mixture. Ensure that the mouse is sufficiently anesthetized by testing its pedal reflex and monitoring its respiration. ! cautIon All experiments with mice should be performed while following institutional and national guidelines.
2|
Apply an ophthalmic lubricant to the eyes.
3|
Remove a 10-mm circular disk of skin and connective tissue from the skull in the posterior part of the head. Expose and clean the periosteum to the temporal crests with a sterile cotton swab. 4| Place the mouse in the stereotactic frame and stabilize the head under the bright-field stereomicroscope.  crItIcal step Ensure that the position of the mouse is secure.
5|
Wash the scalp with sterile saline.  crItIcal step Do not apply ethanol to open wounds or an exposed skull.  crItIcal step All surgical tools must be sterile.
6|
Using a scalpel, detach the cervical trapezius muscle from the skull, and move it posterior to its attached location, so as to fully expose the skull above the cerebellum (Fig. 1a) . ! cautIon Bleeding will occur during this step.
? trouBlesHootInG
7|
At this point, all further procedures should be performed under the stereomicroscope. Using a pen, draw a 6-mm circle over the parietal and occipital regions of the skull.
8|
Use a high-speed bone microdrill with a 1.4-mm-diameter burr tip to make a groove around the margins of the circle (Fig. 1b) .  crItIcal step Drill slowly and apply cold saline regularly to avoid thermally induced injury to the brain.  crItIcal step The bone overlying the cerebellum is thin. Drill slowly and carefully to avoid damage. ? trouBlesHootInG 9| Deepen the groove gradually by repetitive drilling, until the bone flap becomes loose and/or the cerebellar surface vessels become visible.  crItIcal step Do not apply excessive pressure. Check the depth of the groove and the thickness of the skull. Some bleeding from the skull may occur.
? trouBlesHootInG 10| Use a no. 3 Dumont forceps with great caution to separate the bone flap from the dura mater underneath (Fig. 1c) .  crItIcal step Use sterile saline when removing the bone flap. Be careful not to damage the cerebellar surface vasculature.
11|
Remove the bone flap very slowly (Fig. 1d) .  crItIcal step The dura is attached to the cranium. Dura capillaries may tear, resulting in bleeding. Use Gelfoam and sterile saline to stop the bleeding.
? trouBlesHootInG 12| Place a piece of Gelfoam that has been soaked in saline on the dura mater, and rinse it continuously with sterile saline to keep the cerebellum moist.
13| Use a Dumont no. 3 forceps to remove small pieces of bone attached to the edge of the circle.
14|
Place Gelfoam on the edge of the cut to absorb saline and/or blood.
15|
Use a Dumont no. 5 forceps to make a small opening in the dura mater near the edge.  crItIcal step Do not make the opening close to large cerebellar vessels.
16|
Insert the Vannas spring scissors into the opening and cut the dura and the arachnoid membranes from the surface of the cerebellum completely, avoiding damage to large vessels when possible.  crItIcal step Start removing the dura from the periphery very slowly. Avoid pulling the dura or putting pressure on the surface of the cerebellum. Bleeding may occur during this step; use Gelfoam and sterile saline to stop the bleeding. ? trouBlesHootInG 17| Rinse the surface of the cerebellum with sterile saline.
18| Place a 7-mm-diameter round coverslip (glass or polyethylene) to cover the surface of the exposed cerebellum (Fig. 1e) . Use saline to keep the surface wet during this procedure (Fig. 1f) . The skull bone should remain dry around the opening.  crItIcal step The coverslip should remain as close to the surface as possible.  crItIcal step The choice of the coverslip (glass or polyethylene) depends on the imaging application. For multiphoton microscopy, a glass coverslip is preferred, as polyethylene may be burned rapidly by the laser, leading to impairment of the image quality. For ultrasound imaging, a polyethylene coverslip is required because it causes less reflection and enables superior image quality.
19|
Fix the coverslip to the bone with a 1:1 mixture of a histocompatible cyanoacrylate glue and fine acrylic powder (Fig. 1g,h ). Apply the mixture before it sets.  crItIcal step The skull bone should be dried with a dry cotton swab before applying the glue. If the bone is wet, the coverslip can become loose. Be careful to avoid allowing the glue to contact the surface of the cerebellum.
Saline should be applied on the exposed surface of the cerebellum to the edge of the coverslip; this will exclude any glue that may escape the demarcated boundary.
20|
Monitor the mouse post surgery, and allow it to rest on the heating pad until it awakens.
21|
Once the mouse is awake, place it in its cage, one mouse per cage.  crItIcal step If you put more than one mouse in a cage, they may damage the coverslips of their cage mates, leading to potential cerebellar injuries. 22| Administer buprenorphine at a concentration of 0.1 mg/kg body weight 15 min before surgery. Anesthetize the mouse with the ketamine and xylazine mixture (90 and 9 mg/kg body weight, respectively).
23|
24|
Place the mouse in the stereotactic frame under the bright-field stereomicroscope, and ensure that the head is stabilized.  crItIcal step Ensure that the position of the mouse is secure.
25| Use forceps to carefully remove the cerebellar window. Remove the coverslip and glue with a Dumont no. 3 forceps.  crItIcal step Remove the cerebellar window very carefully to avoid damage to the coverslip and injuries to the cerebellum. If the window is more than 2 weeks old, it may be necessary to use a 30-gauge needle to gently break the interface between the glue and the coverslip, leaving the glue ring intact on the bone in order to remove only the coverslip.
26|
Note the presence of bony regrowth from the skull that may obscure the imaging window. If such a regrowth is present, remove it delicately with fine forceps.
27|
Use a dry cotton swab and forceps to clean the bone around the window area.
28|
Rinse the cerebellum continuously with sterile saline.
29| Place Gelfoam to absorb the saline and/or blood.
30|
Place a Hamilton syringe with the 28-gauge needle filled with medulloblastoma cells (~10,000/µl) on the stereotactic injection device at an angle of 0-10 degrees from perpendicular to the work surface (0-10 degrees offset from the vertical plane). 
35|
Move the needle 2.0-2.5 mm dorsal from its previous position.
36|
Carefully lower the needle until it touches, but does not puncture, the surface of the cerebellar hemisphere.
37|
Lower the needle ~1 mm into the cerebellum.  crItIcal step Surface capillaries may tear, resulting in bleeding. Use Gelfoam and sterile saline to stop the bleeding.
38|
Retract the needle ~0.5 mm.
39| Inject 1 µl of cell suspension over 2 min.
40|
Rinse the surface of the cerebellum with sterile saline.
41|
Retract the needle over 3-5 min, until it exits the cerebellum, rinsing the surface of the cerebellum continuously with sterile saline.  crItIcal step The slow retraction coupled with debridement mitigates the migration of tumor cells to the surface of the tissue.
42|
Place Gelfoam on the cerebellum to absorb saline and/or blood.
43|
Remove the Gelfoam.
44|
Rinse the cerebellum with sterile saline.
45|
Place a new 7-mm-diameter round coverslip (glass or polyethylene).
46|
Fix the coverslip to the bone or to the glue ring with a cyanoacrylate glue/acrylic powder mixture. Add saline to the surface of the cerebellum to the edge of the coverslip to exclude the glue from the cerebellar surface.
47|
Place one mouse in a cage.  crItIcal step If you put more than one mouse in a single cage, they may damage the coverslips of their cage mates' windows, leading to potential cerebellar injuries.
48|
The next day, subcutaneously administer buprenorphine to the mouse at a concentration of 0.1 mg/kg body weight, as needed.
replacement of window (if needed)
• tIMInG 5-15 min 49| The window should remain clear for months. If imaging modality or quality warrants, replace the window as described in Steps 22-29 and 43-48 above.
? trouBlesHootInG ? trouBlesHootInG Troubleshooting advice can be found in table 1.
• tIMInG 
antIcIpateD results
After the establishment of the cerebellar window and after the mouse has recovered from anesthesia, simple visual inspection of the cerebellar window should be performed in order to assess its quality. This can be done within the first 2-3 d post surgery. If hemorrhage or other surgery-related complications have interfered with the optical quality of the window, it will be apparent during this time. As mentioned previously, although we have not observed reactive gliosis in the cerebellum after surgery, we cannot formally exclude it as a possible postsurgical complication; we generally wait at least 7 d before proceeding to further imaging or tumor implantation. After tumor implantation, imaging of lesions is generally not feasible until 1-2 weeks after implantation, depending on the aggressiveness of the implanted cells and the number of cells injected, as the implanted tumor cells will not have 
